These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 23391119)

  • 21. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
    Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A
    Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytologic appearances of pheochromocytoma and medullary thyroid carcinoma occurring within a family.
    Tsuzaki K; Tanaka I; Kotoh K
    Acta Cytol; 1978; 22(5):321-6. PubMed ID: 281838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors.
    Liu T; Brown TC; Juhlin CC; Andreasson A; Wang N; Bäckdahl M; Healy JM; Prasad ML; Korah R; Carling T; Xu D; Larsson C
    Endocr Relat Cancer; 2014 Jun; 21(3):427-34. PubMed ID: 24803525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes.
    Gimenez-Roqueplo AP; Dahia PL; Robledo M
    Horm Metab Res; 2012 May; 44(5):328-33. PubMed ID: 22328163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma.
    Burnichon N; Vescovo L; Amar L; Libé R; de Reynies A; Venisse A; Jouanno E; Laurendeau I; Parfait B; Bertherat J; Plouin PF; Jeunemaitre X; Favier J; Gimenez-Roqueplo AP
    Hum Mol Genet; 2011 Oct; 20(20):3974-85. PubMed ID: 21784903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PCSK2 expression in neuroendocrine tumors points to a midgut, pulmonary, or pheochromocytoma-paraganglioma origin.
    Remes SM; Leijon H; Vesterinen T; Louhimo J; Pulkkinen V; Ezer S; Kere J; Haglund C; Arola J
    APMIS; 2020 Nov; 128(11):563-572. PubMed ID: 32794589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas.
    Garcia-Carbonero R; Matute Teresa F; Mercader-Cidoncha E; Mitjavila-Casanovas M; Robledo M; Tena I; Alvarez-Escola C; Arístegui M; Bella-Cueto MR; Ferrer-Albiach C; Hanzu FA
    Clin Transl Oncol; 2021 Oct; 23(10):1995-2019. PubMed ID: 33959901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinomas. Implications for the differential diagnosis of adrenal gland tumors.
    Komminoth P; Roth J; Schröder S; Saremaslani P; Heitz PU
    Lab Invest; 1995 Apr; 72(4):424-31. PubMed ID: 7723281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pheochromocytoma: an update on genetics and management.
    Karagiannis A; Mikhailidis DP; Athyros VG; Harsoulis F
    Endocr Relat Cancer; 2007 Dec; 14(4):935-56. PubMed ID: 18045948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Guide to Pheochromocytomas and Paragangliomas.
    Guilmette J; Sadow PM
    Surg Pathol Clin; 2019 Dec; 12(4):951-965. PubMed ID: 31672301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concurrent pheochromocytoma and cortical carcinoma of the adrenal gland.
    Fassina A; Cappellesso R; Schiavi F; Fassan M
    J Surg Oncol; 2011 Jan; 103(1):103-4. PubMed ID: 21031430
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of Pheochromocytomas and Paragangliomas.
    Passman JE; Wachtel H
    Surg Clin North Am; 2024 Aug; 104(4):863-881. PubMed ID: 38944505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Familial pheochromocytomas and paragangliomas.
    King KS; Pacak K
    Mol Cell Endocrinol; 2014 Apr; 386(1-2):92-100. PubMed ID: 23933153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular imaging and theranostic approaches in pheochromocytoma and paraganglioma.
    Taïeb D; Pacak K
    Cell Tissue Res; 2018 May; 372(2):393-401. PubMed ID: 29450723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular abnormalities in tumors associated with multiple endocrine neoplasia type 2.
    Nelkin BD; Ball DW; Baylin SB
    Endocrinol Metab Clin North Am; 1994 Mar; 23(1):187-213. PubMed ID: 7913025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetics of Pheochromocytomas and Paragangliomas Determine the Therapeutical Approach.
    Sarkadi B; Saskoi E; Butz H; Patocs A
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo.
    Oliveira MN; Hemerly JP; Bastos AU; Tamanaha R; Latini FR; Camacho CP; Impellizzeri A; Maciel RM; Cerutti JM
    Thyroid; 2011 Sep; 21(9):975-85. PubMed ID: 21834681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One hundred and seven family members with the rearranged during transfection V804M proto-oncogene mutation presenting with simultaneous medullary and papillary thyroid carcinomas, rare primary hyperparathyroidism, and no pheochromocytomas: is this a new syndrome--MEN 2C?
    Shifrin AL; Xenachis C; Fay A; Matulewicz TJ; Kuo YH; Vernick JJ
    Surgery; 2009 Dec; 146(6):998-1005. PubMed ID: 19958926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Pheochromocytoma/Paraganglioma syndrome: an overview on mechanisms, diagnosis and management.
    Lima JV; Kater CE
    Int Braz J Urol; 2023; 49(3):307-319. PubMed ID: 37115176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of pheochromocytomas and abdominal and pelvic paragangliomas with head and neck paragangliomas.
    Al-Harthy M; Al-Harthy S; Al-Otieschan A; Velagapudi S; Alzahrani AS
    Endocr Pract; 2009 Apr; 15(3):194-202. PubMed ID: 19364686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.